Literature DB >> 21868534

Methylation of the homeobox gene, HOPX, is frequently detected in poorly differentiated colorectal cancer.

Yoshikuni Harada1, Kazuhiro Kijima, Kazuki Shinmura, Makiko Sakata, Kazuma Sakuraba, Kazuaki Yokomizo, Youhei Kitamura, Atsushi Shirahata, Tetsuhiro Goto, Hiroki Mizukami, Mitsuo Saito, Gaku Kigawa, Hiroshi Nemoto, Kenji Hibi.   

Abstract

BACKGROUND: Homeodomein only protein x (HOPX) gene methylation has frequently been detected in cancer tissues. The methylation status of the HOPX gene in colorectal cancer was examined and compared to the clinocopathological findings.
MATERIALS AND METHODS: Eighty-nine tumor samples and corresponding normal tissues were obtained from colorectal cancer patients who underwent surgery at our hospital. The methylation status of the HOPX gene in these samples was examined by quantitative methylation-specific PCR (qMSP). Subsequently, the clinicopathological findings were correlated with the methylation status of the HOPX gene.
RESULTS: HOPX gene methylation was found in 46 (52%) out of the 89 colorectal carcinomas, suggesting that it was frequently observed in colorectal cancer. A significant increase of methylation was observed in the poorly differentiated carcinomas (p=0.0049).
CONCLUSION: HOPX gene methylation could play an important role for the development of colorectal cancer and is closely related to the histological type.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21868534

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

Review 1.  HOPX: A Unique Homeodomain Protein in Development and Tumor Suppression.

Authors:  Ravindran Caspa Gokulan; Lee Fah Yap; Ian C Paterson
Journal:  Cancers (Basel)       Date:  2022-06-02       Impact factor: 6.575

2.  Epigenetic silencing of HOPX promotes cancer progression in colorectal cancer.

Authors:  Hiroshi Katoh; Keishi Yamashita; Mina Waraya; Ofer Margalit; Akira Ooki; Hideaki Tamaki; Hiroyuki Sakagami; Kenichi Kokubo; David Sidransky; Masahiko Watanabe
Journal:  Neoplasia       Date:  2012-07       Impact factor: 5.715

3.  Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice.

Authors:  Chien-Chin Lin; Chi-Yuan Yao; Yueh-Chwen Hsu; Hsin-An Hou; Chang-Tsu Yuan; Yi-Hung Li; Chein-Jun Kao; Po-Han Chuang; Yu-Chiao Chiu; Yidong Chen; Wen-Chien Chou; Hwei-Fang Tien
Journal:  Oncogene       Date:  2020-06-12       Impact factor: 9.867

4.  HOPX hypermethylation promotes metastasis via activating SNAIL transcription in nasopharyngeal carcinoma.

Authors:  Xianyue Ren; Xiaojing Yang; Bin Cheng; Xiaozhong Chen; Tianpeng Zhang; Qingmei He; Bin Li; Yingqin Li; Xinran Tang; Xin Wen; Qian Zhong; Tiebang Kang; Musheng Zeng; Na Liu; Jun Ma
Journal:  Nat Commun       Date:  2017-02-01       Impact factor: 14.919

5.  Higher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in de novo acute myeloid leukemia.

Authors:  Chien-Chin Lin; Yueh-Chwen Hsu; Yi-Hung Li; Yuan-Yeh Kuo; Hsin-An Hou; Keng-Hsueh Lan; Tsung-Chih Chen; Yi-Shiuan Tzeng; Yi-Yi Kuo; Chein-Jun Kao; Po-Han Chuang; Mei-Hsuan Tseng; Yu-Chiao Chiu; Wen-Chien Chou; Hwei-Fang Tien
Journal:  Haematologica       Date:  2017-03-24       Impact factor: 9.941

Review 6.  The role of HOPX in normal tissues and tumor progression.

Authors:  Yijun Liu; Wenling Zhang
Journal:  Biosci Rep       Date:  2020-01-31       Impact factor: 3.840

Review 7.  The homeobox only protein homeobox (HOPX) and colorectal cancer.

Authors:  Keishi Yamashita; Hiroshi Katoh; Masahiko Watanabe
Journal:  Int J Mol Sci       Date:  2013-11-25       Impact factor: 5.923

8.  Epigenetic silencing of HOPX is critically involved in aggressive phenotypes and patient prognosis in papillary thyroid cancer.

Authors:  Yosuke Ooizumi; Hiroshi Katoh; Mitsuo Yokota; Masahiko Watanabe; Keishi Yamashita
Journal:  Oncotarget       Date:  2019-10-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.